Machine-learning Algorithm for Prediction of CKD From Retinal Images (healthy route)
A Validation Study to Assess Performance Accuracy of a Machine-Learning Algorithm for the Prediction of Chronic Kidney Disease (CKD) From Digital Retinal Images
This is a non-interventional study being conducted to validate the performance of a machine learning algorithm for prediction of eGFR from digital retinal images in a target population for future intended use as a populated-based screening tool. Secondary objectives will include prediction of blood pressure (> or ≤ 140/90 mmHg) and presence or absence of T2DM as determined by glycated haemoglobin (HbA1c >6.5%) or on the basis of clinical history. Once validated, the methodology will be deployed for health screening to improve access to healthcare.
研究概览
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Mohamed Khalis, Professor
- 电话号码:+212 628-245023
- 邮箱:mkhalis@um6ss.ma
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
The study population consists of adult patients diagnosed with chronic kidney disease (CKD), hypertension, diabetes mellitus, or without these conditions, attending routine outpatient clinics at Hôpital Universitaire International Cheikh Khalifa Ibn Zaid in Casablanca and Centre Hospitalier Universitaire Hassan II in Fez, Morocco.
描述
Inclusion Criteria
Participants are eligible to be included in the study only if all of the following criteria apply:
- Participant must be ≥ 18 years of age, at the time of signing the informed consent.
- Previously documented eGFR ≥ 3months
- Any participant with a positive dipstick result for proteinuria of at least trace
- Capable of giving signed informed consent as described in Appendix A which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol
Exclusion Criteria:
-
Participants are excluded from the study if any of the following criteria apply:
- As judged by the investigator, any evidence of a condition which in the investigator's opinion makes it undesirable for the participant to participate in the study.
- Any known eye condition that may preclude clear imaging of the retina for example; cataracts
- Individuals with hypertensive emergencies and hyperglycemic or hypoglycemic emergencies
- Involvement in the planning and/or conduct of the study (applies to HHA/ AstraZeneca staff and/or staff at the study site).
- Judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures, restrictions and requirements.
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_CONTROL
- 时间观点:CROSS_SECTIONAL
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
CKD Cases
350 participants (cases) with diabetes and/or hypertension and/or CKD with previously documented eGFR < 60 ml/min/1.73m2 ≥3 months |
A machine learning-based algorithm analyzes retinal images to assess its ability to detect chronic kidney disease |
|
Controls
150 (controls) with previously documented eGFR ≥ 60 ml/min/1.73m2 ≥ 3 months |
A machine learning-based algorithm analyzes retinal images to assess its ability to detect chronic kidney disease |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The accuracy of a machine-learning based algorithm to predict high risk CKD from digital retinal images
大体时间:Baseline
|
To quantify the discrimination of the machine-learning algorithm for identifying the binary target condition of persistent eGFR <60 mL/min/1.73 m², using standard-of-care serum creatinine as the reference standard and the AUROC with a 95% confidence interval as the primary performance measure |
Baseline
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Accuracy of the Machine Learning Algorithm for Detection of Hypertension and T2DM
大体时间:Baseline
|
To quantify the sensitivity, specificity, and discriminative performance of a machine-learning-based algorithm for identifying SBP >140 mmHg from digital retinal images, using standard-of-care assessment as the reference standard and the AUROC with a 95% confidence interval as the primary performance measure |
Baseline
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.